Gillian Browne

Global Market Development Scientist-Gene Editing Tools
Merck
Gillian received a BSc in Biomedical Sciences, followed by a PhD in Cellular and Molecular Cancer Biology in the UK. She pursued almost five years of postdoctoral research in the USA and during this time co-authored 13 peer reviewed publications in the field of cancer biology, with a focus on gene regulation. Gillian spent her most recent years enabling other scientists and colleagues with her work at companies, and today, she serves as a global strategic scientific and business partner to the commercial teams, as well as to our gene editing customers around the world.

Sessions

November 8 2019, 08:00
 - 09:30
Discussion Workshop And Breakfast: The Advancement Of CRISPR In Discovery And Therapeutic Development